Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 10/20 | 0.64 |
| ▸ | CTSS | P25774 | 6/20 | 0.64 |
| ▸ | CTSL | P07711 | 2/20 | 0.45 |
| ▸ | RAB9A | P51151 | 2/20 | 0.45 |
| ▸ | CTSB | P07858 | 1/20 | 0.41 |
| ▸ | PPARA | Q07869 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | ACE | P12821 | 1/20 | 0.40 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.40 |
| ▸ | KLK5 | Q9Y337 | 1/20 | 0.40 |
| ▸ | CTSC | P53634 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10094265 | 1.00 | CTSK (0.64) | CTSKCTSSCTSLRAB9ACTSB | |
| SCHEMBL16478919 | 0.91 | CTSK (0.62) | CTSKCTSSCTSLRAB9ACTSB | |
| SCHEMBL14164208 | 0.89 | CTSK (0.68) | CTSKCTSSCTSLRAB9ACTSB | |
| SCHEMBL844317 | 0.85 | CTSK (0.73) | CTSKCTSSCTSLRAB9ACTSB | |
| SCHEMBL2481878 | 0.85 | CTSK (0.73) | CTSKCTSSCTSLRAB9ACTSB | |
| SCHEMBL844316 | 0.85 | CTSK (0.73) | CTSKCTSSCTSLRAB9ACTSB | |
| SCHEMBL9109963 | 0.84 | CTSK (0.68) | CTSKCTSSCTSLRAB9ACTSB | |
| SCHEMBL9109956 | 0.84 | CTSK (0.68) | CTSKCTSSCTSLRAB9ACTSB | |
| SCHEMBL20830986 | 0.83 | CTSK (0.73) | CTSKCTSSCTSLRAB9ACTSB | |
| SCHEMBL21985765 | 0.81 | CTSK (0.55) | CTSKCTSSCTSLRAB9ACYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140012005-A1 | PROCESS FOR PREPARING CHIRAL AMINO ACIDS | DIVERCHIM (FR) | 2014-01-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140012005-A1 | PROCESS FOR PREPARING CHIRAL AMINO ACIDS | BCAT1, DNPEP, BCAT2 | CTSK 2248/4885CTSS 724/4885CTSL 570/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.